Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Pingchuan Plaster (Chinese name: 平喘敷贴) is a traditional Chinese medicine (TCM) topical formulation used primarily for the relief of symptoms associated with respiratory conditions such as asthma and chronic cough. The term "Pingchuan" translates to "calm wheezing," indicating its intended use in alleviating wheezing and dyspnea. This plaster is typically applied transdermally to specific acupoints or affected areas on the body, where it delivers herbal ingredients through the skin. The mechanism of action is based on TCM principles, aiming to regulate lung qi, resolve phlegm, and relieve bronchospasm; however, its precise pharmacological targets are not well characterized in Western medicine literature. The product may contain a combination of herbal extracts known for their expectorant, anti-inflammatory, or bronchodilatory effects according to TCM theory.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Pingchuan Plaster.